Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Equity Average (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Equity Average for 2 consecutive years, with $48.7 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 49.51% to $48.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.7 million through Dec 2025, down 49.51% year-over-year, with the annual reading at $67.1 million for FY2025, 30.73% down from the prior year.
  • Equity Average hit $48.7 million in Q4 2025 for Connect Biopharma Holdings, down from $63.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $105.8 million in Q3 2024 to a low of $48.7 million in Q4 2025.